Recent development of BTK-based dual inhibitors in the treatment of cancers
Fansheng Ran, Yun Liu, Zhongyuan Xu, Chi Meng, Dezhi Yang, Jianqiang Qian, Xuexian Deng, Yanan Zhang, Yong Ling
Topics & Concepts
Bruton's tyrosine kinaseDrugDrug developmentDrug resistanceTyrosine kinaseIbrutinibPharmacologyMedicineImmunologyLeukemiaBiologyInternal medicineChronic lymphocytic leukemiaReceptorMicrobiologyChronic Lymphocytic Leukemia ResearchProtein Degradation and InhibitorsLymphoma Diagnosis and Treatment